Heart Defects, Congenital Clinical Trial
Official title:
Physical Capacity and Activity in Children With Congenital Heart Disease in Chile
Congenital malformations correspond to defects in organ morphogenesis identifiable at birth
or intrauterine life, affecting 2-3% of births. Inside of these malformations, Congenital
Heart Disease corresponds, in particular, to structural defects of the heart or major blood
vessels thereof may or may not be associated with other types of syndromes.The resolution is
usually surgical.
Also, these patients present a decrease in physical fitness, psychological imbalance, lower
quality of life and risk significant morbidity and mortality from respiratory infections
among other problems.
This can have severe consequences for health in the medium and long term. The habits acquired
during childhood and adolescence are determinant for the adult life, being relevant levels of
activity and physical condition, especially in children with pathologies.
In this way, it is vital to know from childhood parameters that indicate the baseline state
of these patients according to the levels of physical activity, exercise capacity,
nutritional status and quality of life. These will be key indicators to take into account in
the future, to adapt rehabilitation plans that will reduce the effects of their condition.
The objective of this protocol is To characterize the levels of Activity, and Physical
Capacity of children with congenital heart disease regularly treated at the Cardiovascular
Center of Dr. Luis Hospital Calvo Mackenna, compared to healthy children matched by age and
sex.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05330338 -
Genetics of Ventriculo-arterial Discordance
|
N/A | |
| Withdrawn |
NCT03405636 -
Xeltis Pulmonary Valved Conduit Safety and Performance Study
|
N/A | |
| Completed |
NCT02443662 -
Colloid Osmotic Pressure in Patients With Fontan Circulation
|
||
| Terminated |
NCT02519335 -
Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
|
Phase 1 | |
| Completed |
NCT01835392 -
Neuroprotective Effects of Remote Ischemic Preconditioning (RIPC) During Infant Cardiac Surgery
|
N/A | |
| Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
| Completed |
NCT03035552 -
CTICU Pacifier Activated Music Player and Mother's Voice
|
N/A | |
| Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
| Enrolling by invitation |
NCT04866537 -
Evaluation of the Diagnostic Performance of Specialized Fetal Cardiac Ultrasound in the CPDPN - Arc Alpin Network
|
||
| Completed |
NCT03049540 -
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function
|
Phase 3 | |
| Completed |
NCT02377674 -
Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection
|
N/A | |
| Completed |
NCT01679275 -
Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease
|
||
| Terminated |
NCT00543309 -
Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery
|
Phase 2 | |
| Completed |
NCT03957512 -
Livet Skal Leves (A Life to Live)
|
||
| Recruiting |
NCT06005428 -
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
|
Phase 2 | |
| Recruiting |
NCT02691689 -
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
|
N/A | |
| Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
| Recruiting |
NCT02157597 -
NIRS Guidance Trail in Children's Heart Surgery
|
N/A | |
| Completed |
NCT01570933 -
Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.
|
Phase 4 | |
| Completed |
NCT00396877 -
Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation
|
Phase 3 |